We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
The Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology announced a proposed rule on Monday that would represent a significant rollback of ...
BeOne Medicines maintains Strong Buy as Brukinsa and Tevimbra drive robust growth and pipeline catalysts approach. Q3 2025 marked a pivotal inflection point with 41% YoY sales growth and positive ...
From right to left: Steve Posnack, principal deputy secretary, ASTP/ONC; Carolyn Clancy, deputy under secretary for health, VA; Grace Cordovano, patient-in-residence, DiMe Building a better healthcare ...
Please provide your email address to receive an email when new articles are posted on . Most fellowship programs provide clinical training for community-based careers; fewer offer nonclinical training ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Ellen Lee Ellen Lee is a writer focused on baby and kid gear. She’s texted or ...
Onc.AI’s poster presentation showcases its FDA-breakthrough designated deep learning radiomics model, Serial CTRS, which evaluates changes across routine CT scans over time to predict overall survival ...
Exclusive: Woman dragged from car by ICE agents speaks out for first time Why you might get a "peanut butter"-style pay raise in 2026 Bitter cold continues as major winter storm takes aim at South ...
BeiGene, Ltd., soon to be BeOne Medicines, is a global oncology company with a strong focus on innovative cancer treatments, particularly Brukinsa and Tevimbra. Brukinsa, a BTK inhibitor, has shown ...
SAN CARLOS, Calif. & WATERLOO, Ontario--(BUSINESS WIRE)--Onc.AI, a digital health company developing AI-driven oncology clinical management solutions using Deep Learning imaging AI, today announced ...
Casey Ross covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and privacy. The Trump administration has indefinitely canceled meetings of a health ...
ONC is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of ONC shares has decreased $16.77 since the market last closed. This is a 4.54% ...